Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Change in Receivables (2021 - 2025)

MedWellAI (MWAI) has disclosed Change in Receivables for 4 consecutive years, with -$287.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Receivables rose 76.08% to -$287.0 in Q3 2025 year-over-year; TTM through Dec 2025 was -$26899.0, a 211.97% decrease, with the full-year FY2025 number at -$2588.0, changed N/A from a year prior.
  • Change in Receivables was -$287.0 for Q3 2025 at MedWellAI, up from -$132239.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $127826.0 in Q1 2021 to a low of -$132239.0 in Q2 2025.
  • A 4-year average of $13516.7 and a median of $12468.5 in 2024 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: plummeted 164.98% in 2022, then soared 76.08% in 2025.
  • MedWellAI's Change in Receivables stood at -$81030.0 in 2021, then soared by 61.55% to -$31153.0 in 2022, then skyrocketed by 180.97% to $25224.0 in 2024, then crashed by 101.14% to -$287.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Change in Receivables are -$287.0 (Q3 2025), -$132239.0 (Q2 2025), and $105627.0 (Q1 2025).